Healthcare
Nanox.AI advances AI cardiac collaboration in Thailand
Nanox.AI and Dosy Health advanced collaboration to bring an AI cardiac solution to Thailand after hospitals expressed interest at a medical-AI summit.
Nanox.AI advanced a commercial collaboration with Dosy Health to bring an AI cardiac solution to Thailand. The development followed participation by Dosy Health’s chief executive, Sahatus Asawadilockchai, in the Global Medical AI Summit in Thailand, where several hospitals reportedly expressed interest in the proposed solutions. The announcement illustrates how medical-AI companies are seeking regional commercialization partners to introduce diagnostic or clinical-support products into new healthcare markets. It also shows the role of industry events in connecting technology providers with hospitals and local health-sector representatives. The supplied article identifies the collaboration and the interest expressed by hospitals but does not provide detailed technical specifications for the cardiac system, deployment timelines, regulatory approvals, or confirmed customer contracts. Accordingly, the development should be viewed as a commercial-advancement announcement rather than evidence of broad clinical implementation. Its relevance to healthcare AI lies in the international transfer and localization of AI-enabled cardiac-care technology. Thailand’s participation gives the story an Asian regional focus, while Nanox.AI and Dosy Health represent the technology and local-commercialization sides of the arrangement. Further reporting would be needed to determine whether the collaboration leads to validated use in hospitals or measurable improvements in diagnosis, workflow, or patient outcomes.
Original source: GlobeNewswire